Chemoinformaics analysis of 6-Demethoxycapillarisin
| Molecular Weight | 286.239 | nRot | 2 |
| Heavy Atom Molecular Weight | 276.159 | nRig | 14 |
| Exact Molecular Weight | 286.048 | nRing | 3 |
| Solubility: LogS | -4.801 | nHRing | 1 |
| Solubility: LogP | 4.474 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 31 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 21 | No. of Aromatic Carbocycles | 2 |
| nHetero | 6 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 10 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
| No. of Oxygen atom | 6 | No. of Arom Bond | 17 |
| nHA | 6 | APOL | 36.5299 |
| nHD | 3 | BPOL | 14.3721 |
| QED | 0.662 |
| Synth | 5.086 |
| Natural Product Likeliness | 2.916 |
| NR-PPAR-gamma | 0.006 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.046 |
| Pgp-sub | 0 |
| HIA | 0.006 |
| CACO-2 | -4.7 |
| MDCK | 0.0000139 |
| BBB | 0.847 |
| PPB | 0.917713 |
| VDSS | 1.308 |
| FU | 0.134638 |
| CYP1A2-inh | 0.054 |
| CYP1A2-sub | 0.488 |
| CYP2c19-inh | 0.148 |
| CYP2c19-sub | 0.882 |
| CYP2c9-inh | 0.155 |
| CYP2c9-sub | 0.72 |
| CYP2d6-inh | 0.031 |
| CYP2d6-sub | 0.464 |
| CYP3a4-inh | 0.588 |
| CYP3a4-sub | 0.18 |
| CL | 13.794 |
| T12 | 0.089 |
| hERG | 0.027 |
| Ames | 0.022 |
| ROA | 0.05 |
| SkinSen | 0.714 |
| Carcinogencity | 0.058 |
| EI | 0.169 |
| Respiratory | 0.614 |
| NR-Aromatase | 0.088 |
| Antiviral | Yes |
| Prediction | 0.768032 |